Mevion Medical Systems, a Littleton firm providing proton therapy, will bring its services to Taiwan in a new agreement announced Tuesday.
Mevion’s proton therapy, a type of radiation therapy for cancer patients, will be performed under a collaboration with Chung Shan Medical University Hospital in Taichung City, Taiwan. A third member of the agreement is Marlborugh’s ASYS Corp., a biomedical healthcare engineering, sales and services firm.
Mevion’s new deal will expand its existing international experience in Asia and Europe. Chung Shan Medical University Hospital is the leading healthcare provider in the central region of Taiwan, and has been proactively exploring advanced therapies, such as proton therapy, Mevion said.
Proton therapy, according to Mevion, is a more precise therapeutic radiation to tumors and less damaging to nearby organs.
